Will American Tower Stock Recover?
The performance of the real estate investment trust, or REIT,…
Sell
28
TERN Quote, Financials, Valuation and Earnings
Last price:
$5.72
Seasonality move
:
-10.62%
Day range:
$5.59 - $5.80
52-week range:
$4.32 - $11.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.34x
Volume:
930.4K
Avg. volume:
1.9M
1-year change:
-8.59%
Market cap:
$488.4M
Revenue:
--
EPS (TTM):
-$1.18
Earnings Data
Next earnings date for TERN
Mar 14
2025
Most recent earnings per share
-$0.28
Beat by $0.04
(Nov 12/2024)
Consensus Estimate
-$0.32
(Nov 12/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TERN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q1 | -- | -- | -- | -$0.32 | -- |
| 03/14/2025 | Q4 | -- | -- | -- | -$0.30 | -- |
| 11/12/2024 | Q3 | -- | -- | -$0.28 | -$0.32 | $0.04 |
| 08/05/2024 | Q2 | -- | -- | -$0.31 | -$0.34 | $0.03 |
| 05/13/2024 | Q1 | -- | -- | -$0.30 | -$0.35 | $0.05 |
| 03/14/2024 | Q4 | -- | -- | -$0.29 | -$0.29 | $0.00 |
| 11/14/2023 | Q3 | -- | -- | -$0.42 | -$0.31 | -$0.11 |
| 08/08/2023 | Q2 | -- | -- | -$0.25 | -$0.33 | $0.08 |
| 05/15/2023 | Q1 | -- | -- | -$0.31 | -$0.27 | -$0.04 |
| 03/27/2023 | Q4 | -- | -- | -$0.29 | -$0.44 | $0.15 |
| 11/09/2022 | Q3 | -- | -- | -$0.44 | -- | -- |
| 08/08/2022 | Q2 | -- | -- | -$0.55 | -- | -- |
| 05/16/2022 | Q1 | -- | -- | -$0.55 | -- | -- |
| 03/03/2022 | Q4 | -- | -- | -$0.56 | -- | -- |
| 11/15/2021 | Q3 | -- | -- | -$0.47 | -- | -- |
| 08/16/2021 | Q2 | -- | -- | -$0.43 | -- | -- |
| 05/14/2021 | Q1 | -- | -- | -$0.88 | -- | -- |
| 12/31/2020 | Q4 | -- | -- | $0.03 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.48 | -- | -- |
| 06/30/2020 | Q2 | -- | -- | -$0.40 | -- | -- |
| 03/31/2020 | Q1 | -- | -- | -$0.38 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$0.41 | -- | -- |
Terns Pharmaceuticals Earnings Questions
-
How Much did Terns Pharmaceuticals Generate in Revenue Last Quarter?
Terns Pharmaceuticals reported -- worth of top line sales in its most recent quarter.
-
Did Terns Pharmaceuticals Beat Earnings Last Quarter?
Terns Pharmaceuticals announced earnings per share of -$0.28 which represents a beat of analyst forecast a -$0.32 per share.
-
Is Terns Pharmaceuticals Profitable?
Terns Pharmaceuticals reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Terns Pharmaceuticals EPS Next Year?
Terns Pharmaceuticals's earnings are forecast to decrease from -$1.27 per share to -$1.19 per share next year representing a decrease of -5.91%.
-
When is Terns Pharmaceuticals's Earnings Date?
Terns Pharmaceuticals's next earnings date is March 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Booking Holdings Stock Split?
Booking Holdings, the travel and technology company that owns brands…
Why Buy Domino’s Pizza Stock?
When you think of growth stocks, you probably imagine technology…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 40x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 121x
Sell
46
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Buy
70
OKLO alert for Jan 6
Oklo [OKLO] is up 10.09% over the past day.
Sell
39
DOGZ alert for Jan 6
Dogness (International) [DOGZ] is up 3.39% over the past day.
Buy
66
DMRC alert for Jan 6
Digimarc [DMRC] is up 1.05% over the past day.
